Scientists in Scotland discovered the medications, which target cells that activate vitamin A, may be therapeutic for ...

Both Adzenys and Adderall are stimulant-based drugs that target neurotransmitters in the brain, but there are some ...

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of ...

It's gained greater awareness, thanks to grass roots initiatives. Learn about ALS based on a patient's experience and a ...

The biopharmaceutical company is focusing on a new drug after releasing disappointing data from an Alzheimer's drug earlier ...

ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion ...

Ractigen's therapy candidate RAG-17 was safe across all tested doses and showed early signs of effectiveness in SOD1-ALS ...

PharmAust (ASX:PAA) has submitted a request for OMPD to the European Medicines Agency (EMA) for its lead drug monepantel.

A chance encounter with an inspiring ALS patient, prompted Alon Ben-Noon to set up NeuroSense Therapeutics, a startup ...

People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of ...

Saints hero Steve Gleason, diagnosed with ALS in 2011, is stable after suffering medical event as Hurricane Francine made ...

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP ...